Cargando…
Molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort
The prognostic significance of 1p19q loss in astrocytic gliomas has been inconclusive. We collected 57 gliomas with total 1p19q loss from among 218 cases of WHO grade-II/III gliomas operated at Keio University Hospital between 1990 and 2010. These tumors were classified as oligodendroglial or “astro...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599243/ https://www.ncbi.nlm.nih.gov/pubmed/25991674 |
_version_ | 1782394214153191424 |
---|---|
author | Hayashi, Saeko Sasaki, Hikaru Kimura, Tokuhiro Abe, Takayuki Nakamura, Takumi Kitamura, Yohei Miwa, Tomoru Kameyama, Kaori Hirose, Yuichi Yoshida, Kazunari |
author_facet | Hayashi, Saeko Sasaki, Hikaru Kimura, Tokuhiro Abe, Takayuki Nakamura, Takumi Kitamura, Yohei Miwa, Tomoru Kameyama, Kaori Hirose, Yuichi Yoshida, Kazunari |
author_sort | Hayashi, Saeko |
collection | PubMed |
description | The prognostic significance of 1p19q loss in astrocytic gliomas has been inconclusive. We collected 57 gliomas with total 1p19q loss from among 218 cases of WHO grade-II/III gliomas operated at Keio University Hospital between 1990 and 2010. These tumors were classified as oligodendroglial or “astrocytic” by a WHO-criteria-based institutional diagnosis. Chromosomal copy number aberrations (CNAs), IDH 1/2 mutations, MGMT promoter methylation, and expression of p53 and ATRX were assessed. Survival outcome was compared between the two histological groups. Of the 57 codeleted gliomas, 37, 16, and four were classified as oligodendroglial, “astrocytic”, and unclassified, respectively. Comparative genomic hybridization revealed that although chromosome 7q/7 gain was more frequent in “astrocytic” gliomas, other CNAs occurred at a similar frequency in both groups. None of the “astrocytic” gliomas showed p53 accumulation, and ATRX loss was found in three of the 15 “astrocytic” gliomas. The estimated overall survival (OS) curves in the patients with codeleted oligodendroglial and “astrocytic” gliomas overlapped, and the median OS was 187 and 184 months, respectively. Histopathological re-assessment by a single pathologist showed consistent results. Gliomas with total 1p19q loss with “astrocytic” features have molecular and biological characteristics comparable to those of oligodendroglial tumors. |
format | Online Article Text |
id | pubmed-4599243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-45992432015-10-26 Molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort Hayashi, Saeko Sasaki, Hikaru Kimura, Tokuhiro Abe, Takayuki Nakamura, Takumi Kitamura, Yohei Miwa, Tomoru Kameyama, Kaori Hirose, Yuichi Yoshida, Kazunari Oncotarget Research Paper: Pathology The prognostic significance of 1p19q loss in astrocytic gliomas has been inconclusive. We collected 57 gliomas with total 1p19q loss from among 218 cases of WHO grade-II/III gliomas operated at Keio University Hospital between 1990 and 2010. These tumors were classified as oligodendroglial or “astrocytic” by a WHO-criteria-based institutional diagnosis. Chromosomal copy number aberrations (CNAs), IDH 1/2 mutations, MGMT promoter methylation, and expression of p53 and ATRX were assessed. Survival outcome was compared between the two histological groups. Of the 57 codeleted gliomas, 37, 16, and four were classified as oligodendroglial, “astrocytic”, and unclassified, respectively. Comparative genomic hybridization revealed that although chromosome 7q/7 gain was more frequent in “astrocytic” gliomas, other CNAs occurred at a similar frequency in both groups. None of the “astrocytic” gliomas showed p53 accumulation, and ATRX loss was found in three of the 15 “astrocytic” gliomas. The estimated overall survival (OS) curves in the patients with codeleted oligodendroglial and “astrocytic” gliomas overlapped, and the median OS was 187 and 184 months, respectively. Histopathological re-assessment by a single pathologist showed consistent results. Gliomas with total 1p19q loss with “astrocytic” features have molecular and biological characteristics comparable to those of oligodendroglial tumors. Impact Journals LLC 2015-05-11 /pmc/articles/PMC4599243/ /pubmed/25991674 Text en Copyright: © 2015 Hayashi et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper: Pathology Hayashi, Saeko Sasaki, Hikaru Kimura, Tokuhiro Abe, Takayuki Nakamura, Takumi Kitamura, Yohei Miwa, Tomoru Kameyama, Kaori Hirose, Yuichi Yoshida, Kazunari Molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort |
title | Molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort |
title_full | Molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort |
title_fullStr | Molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort |
title_full_unstemmed | Molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort |
title_short | Molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort |
title_sort | molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort |
topic | Research Paper: Pathology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599243/ https://www.ncbi.nlm.nih.gov/pubmed/25991674 |
work_keys_str_mv | AT hayashisaeko moleculargeneticandclinicalcharacteristicsofgliomaswithastrocyticappearanceandtotal1p19qlossinasingleinstitutionalconsecutivecohort AT sasakihikaru moleculargeneticandclinicalcharacteristicsofgliomaswithastrocyticappearanceandtotal1p19qlossinasingleinstitutionalconsecutivecohort AT kimuratokuhiro moleculargeneticandclinicalcharacteristicsofgliomaswithastrocyticappearanceandtotal1p19qlossinasingleinstitutionalconsecutivecohort AT abetakayuki moleculargeneticandclinicalcharacteristicsofgliomaswithastrocyticappearanceandtotal1p19qlossinasingleinstitutionalconsecutivecohort AT nakamuratakumi moleculargeneticandclinicalcharacteristicsofgliomaswithastrocyticappearanceandtotal1p19qlossinasingleinstitutionalconsecutivecohort AT kitamurayohei moleculargeneticandclinicalcharacteristicsofgliomaswithastrocyticappearanceandtotal1p19qlossinasingleinstitutionalconsecutivecohort AT miwatomoru moleculargeneticandclinicalcharacteristicsofgliomaswithastrocyticappearanceandtotal1p19qlossinasingleinstitutionalconsecutivecohort AT kameyamakaori moleculargeneticandclinicalcharacteristicsofgliomaswithastrocyticappearanceandtotal1p19qlossinasingleinstitutionalconsecutivecohort AT hiroseyuichi moleculargeneticandclinicalcharacteristicsofgliomaswithastrocyticappearanceandtotal1p19qlossinasingleinstitutionalconsecutivecohort AT yoshidakazunari moleculargeneticandclinicalcharacteristicsofgliomaswithastrocyticappearanceandtotal1p19qlossinasingleinstitutionalconsecutivecohort |